{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:03:42Z","timestamp":1767866622263,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI123131"],"award-info":[{"award-number":["1R01AI123131"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004829","name":"Connecticut Innovations","doi-asserted-by":"publisher","award":["16-RMB-UCONN-02"],"award-info":[{"award-number":["16-RMB-UCONN-02"]}],"id":[{"id":"10.13039\/100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1347-1","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T13:02:27Z","timestamp":1565096547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes"],"prefix":"10.1186","volume":"10","author":[{"given":"Min","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4581-7642","authenticated-orcid":false,"given":"Laijun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3083.2008.02120.x","volume":"68","author":"AA Chentoufi","year":"2008","unstructured":"Chentoufi AA, Binder NR, Berka N, Abunadi T, Polychronakos C. Advances in type I diabetes associated tolerance mechanisms. Scand J Immunol. 2008;68:1\u201311.","journal-title":"Scand J Immunol"},{"key":"1347_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2337\/diabetes.53.2.267","volume":"53","author":"AA Rossini","year":"2004","unstructured":"Rossini AA. Autoimmune diabetes and the circle of tolerance. Diabetes. 2004;53:267\u201375.","journal-title":"Diabetes"},{"key":"1347_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11892-016-0807-6","volume":"16","author":"A Spence","year":"2016","unstructured":"Spence A, Tang Q. Restoring regulatory T cells in type 1 diabetes. Current Diab Rep. 2016;16:110.","journal-title":"Current Diab Rep"},{"key":"1347_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nri2192","volume":"7","author":"M von Herrath","year":"2007","unstructured":"von Herrath M, Sanda S, Herold K. Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol. 2007;7:988\u201394.","journal-title":"Nat Rev Immunol"},{"key":"1347_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol. 2005;23:447\u201385.","journal-title":"Annu Rev Immunol"},{"key":"1347_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/genes4030499","volume":"4","author":"M Bakay","year":"2013","unstructured":"Bakay M, Pandey R, Hakonarson H. Genes involved in type 1 diabetes: an update. Genes. 2013;4:499\u2013521.","journal-title":"Genes"},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni726","volume":"2","author":"H Kishimoto","year":"2001","unstructured":"Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol. 2001;2:1025\u201331.","journal-title":"Nat Immunol"},{"key":"1347_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.immuni.2005.01.015","volume":"22","author":"S Zucchelli","year":"2005","unstructured":"Zucchelli S, Holler P, Yamagata T, Roy M, Benoist C, Mathis D. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity. 2005;22:385\u201396.","journal-title":"Immunity"},{"key":"1347_CR9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.156.2.450","volume":"156","author":"E Carrasco-Marin","year":"1996","unstructured":"Carrasco-Marin E, Shimizu J, Kanagawa O, Unanue ER. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol. 1996;156:450\u20138.","journal-title":"J Immunol"},{"key":"1347_CR10","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.4049\/jimmunol.165.6.3214","volume":"165","author":"T Stratmann","year":"2000","unstructured":"Stratmann T, Apostolopoulos V, Mallet-Designe V, Corper AL, Scott CA, Wilson IA, et al. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J Immunol. 2000;165:3214\u201325.","journal-title":"J Immunol"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1073\/pnas.1006545107","volume":"107","author":"BD Stadinski","year":"2010","unstructured":"Stadinski BD, Zhang L, Crawford F, Marrack P, Eisenbarth GS, Kappler JW. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A. 2010;107:10978\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1084\/jem.20111502","volume":"208","author":"JF Mohan","year":"2011","unstructured":"Mohan JF, Petzold SJ, Unanue ER. Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion. J Exp Med. 2011;208:2375\u201383.","journal-title":"J Exp Med"},{"key":"1347_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1084\/jem.187.3.379","volume":"187","author":"F Luhder","year":"1998","unstructured":"Luhder F, Katz J, Benoist C, Mathis D. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J Exp Med. 1998;187:379\u201387.","journal-title":"J Exp Med"},{"key":"1347_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/345724a0","volume":"345","author":"RM Slattery","year":"1990","unstructured":"Slattery RM, Kjer-Nielsen L, Allison J, Charlton B, Mandel TE, Miller JF. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature. 1990;345:724\u20136.","journal-title":"Nature"},{"key":"1347_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2337\/diabetes.52.1.59","volume":"52","author":"GF Beilhack","year":"2003","unstructured":"Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabek L, Burge MJ, et al. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes. 2003;52:59\u201368.","journal-title":"Diabetes"},{"key":"1347_CR16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.156.1.380","volume":"156","author":"H Li","year":"1996","unstructured":"Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol. 1996;156:380\u20138.","journal-title":"J Immunol"},{"key":"1347_CR17","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1182\/blood-2004-06-2411","volume":"105","author":"Y Liang","year":"2005","unstructured":"Liang Y, Huang T, Zhang C, Todorov I, Atkinson M, Kandeel F, et al. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood. 2005;105:2180\u20138.","journal-title":"Blood"},{"key":"1347_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2337\/diabetes.53.2.376","volume":"53","author":"B Nikolic","year":"2004","unstructured":"Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes. 2004;53:376\u201383.","journal-title":"Diabetes"},{"key":"1347_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2337\/db10-0827","volume":"60","author":"J Racine","year":"2011","unstructured":"Racine J, Wang M, Zhang C, Lin CL, Liu H, Todorov I, et al. Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice. Diabetes. 2011;60:555\u201364.","journal-title":"Diabetes"},{"key":"1347_CR20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood.V95.6.2175","volume":"95","author":"E Seung","year":"2000","unstructured":"Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD\/Lt mice. Blood. 2000;95:2175\u201382.","journal-title":"Blood"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.4049\/jimmunol.1401137","volume":"193","author":"M Wang","year":"2014","unstructured":"Wang M, Racine J, Zhang M, Wu T, Deng R, Johnston H, et al. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients. J Immunol. 2014;193:2005\u201315.","journal-title":"J Immunol"},{"key":"1347_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1172\/JCI22103","volume":"114","author":"C Tian","year":"2004","unstructured":"Tian C, Bagley J, Cretin N, Seth N, Wucherpfennig KW, Iacomini J. Prevention of type 1 diabetes by gene therapy. J Clin Invest. 2004;114:969\u201378.","journal-title":"J Clin Invest"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2337\/diab.46.1.34","volume":"46","author":"MB French","year":"1997","unstructured":"French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes. 1997;46:34\u20139.","journal-title":"Diabetes"},{"key":"1347_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1568-9972(03)00009-0","volume":"2","author":"P Narendran","year":"2003","unstructured":"Narendran P, Mannering SI, Harrison LC. Proinsulin-a pathogenic autoantigen in type 1 diabetes. Autoimmun Rev. 2003;2:204\u201310.","journal-title":"Autoimmun Rev"},{"key":"1347_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1006\/jaut.2000.0444","volume":"15","author":"DR Wegmann","year":"2000","unstructured":"Wegmann DR, Eisenbarth GS. It's insulin. J Autoimmun. 2000;15:286\u201391.","journal-title":"J Autoimmun"},{"key":"1347_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ng0397-293","volume":"15","author":"A Pugliese","year":"1997","unstructured":"Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 1997;15:293\u20137.","journal-title":"Nat Genet"},{"key":"1347_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng0397-289","volume":"15","author":"P Vafiadis","year":"1997","unstructured":"Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 1997;15:289\u201392.","journal-title":"Nat Genet"},{"key":"1347_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI16584","volume":"111","author":"K Thebault-Baumont","year":"2003","unstructured":"Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest. 2003;111:851\u20137.","journal-title":"J Clin Invest"},{"key":"1347_CR29","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2337\/diab.46.12.1975","volume":"46","author":"M Cetkovic-Cvrlje","year":"1997","unstructured":"Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliott JF, Leiter EH. Retardation or acceleration of diabetes in NOD\/Lt mice mediated by intrathymic administration of candidate beta-cell antigens. Diabetes. 1997;46:1975\u201382.","journal-title":"Diabetes"},{"key":"1347_CR30","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1182\/blood-2006-03-010900","volume":"108","author":"G Marodon","year":"2006","unstructured":"Marodon G, Fisson S, Levacher B, Fabre M, Salomon BL, Klatzmann D. Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors. Blood. 2006;108:2972\u20138.","journal-title":"Blood"},{"key":"1347_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.it.2009.04.003","volume":"30","author":"HE Lynch","year":"2009","unstructured":"Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol. 2009;30:366\u201373.","journal-title":"Trends Immunol"},{"key":"1347_CR32","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/stem.238","volume":"27","author":"L Lai","year":"2009","unstructured":"Lai L, Jin J. Generation of thymic epithelial cell progenitors by mouse embryonic stem cells. Stem Cells. 2009;27:3012\u201320.","journal-title":"Stem Cells"},{"key":"1347_CR33","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1182\/blood-2011-03-340794","volume":"118","author":"L Lai","year":"2011","unstructured":"Lai L, Cui C, Jin J, Hao Z, Zheng Q, Ying M, et al. Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation. Blood. 2011;118:3410\u20138.","journal-title":"Blood"},{"key":"1347_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jaut.2015.01.002","volume":"58","author":"M Su","year":"2015","unstructured":"Su M, Song Y, He Z, Hu R, Rood D, Lai L. Administration of embryonic stem cell-derived thymic epithelial progenitors expressing MOG induces antigen-specific tolerance and ameliorates experimental autoimmune encephalomyelitis. J Autoimmun. 2015;58:36\u201347.","journal-title":"J Autoimmun"},{"key":"1347_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cellimm.2017.10.007","volume":"322","author":"M Su","year":"2017","unstructured":"Su M, Lin Y, Cui C, Tian X, Lu X, He Z, et al. ESC-derived thymic epithelial cells expressing MOG prevents EAE by central and peripheral tolerance mechanisms. Cell Immunol. 2017;322:84\u201391.","journal-title":"Cell Immunol"},{"issue":"1","key":"1347_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5966\/sctm.2016-0012","volume":"6","author":"Rong Hu","year":"2016","unstructured":"Hu R, Liu Y, Su M, Song Y, Rood D, Lai L. Transplantation of donor-origin mouse embryonic stem cell-derived thymic epithelial progenitors prevents the development of chronic graft-versus-host disease in mice. Stem Cells Trans Med. 2017;6:121\u201330.","journal-title":"STEM CELLS Translational Medicine"},{"key":"1347_CR37","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/eji.201546196","volume":"46","author":"Y Song","year":"2016","unstructured":"Song Y, Su M, Zhu J, Di W, Liu Y, Hu R, et al. FOXN1 recombinant protein enhances T-cell regeneration after hematopoietic stem cell transplantation in mice. Eur J Immunol. 2016;46:1518\u201328.","journal-title":"Eur J Immunol"},{"key":"1347_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5966\/sctm.2016-0012","volume":"6","author":"R Hu","year":"2017","unstructured":"Hu R, Liu Y, Su M, Song Y, Rood D, Lai L. Transplantation of donor-origin mouse embryonic stem cell-derived thymic epithelial progenitors prevents the development of chronic graft-versus-host disease in mice. Stem Cells Transl Med. 2017;6:121\u201330.","journal-title":"Stem Cells Transl Med"},{"key":"1347_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI0213605","volume":"109","author":"A Kukreja","year":"2002","unstructured":"Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest. 2002;109:131\u201340.","journal-title":"J Clin Invest"},{"key":"1347_CR40","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2337\/diabetes.51.5.1383","volume":"51","author":"AA Chentoufi","year":"2002","unstructured":"Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 2002;51:1383\u201390.","journal-title":"Diabetes"},{"key":"1347_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1073\/pnas.95.4.1721","volume":"95","author":"O Kanagawa","year":"1998","unstructured":"Kanagawa O, Martin SM, Vaupel BA, Carrasco-Marin E, Unanue ER. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc Natl Acad Sci U S A. 1998;95:1721\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1347_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4049\/jimmunol.177.1.53","volume":"177","author":"B Faideau","year":"2006","unstructured":"Faideau B, Lotton C, Lucas B, Tardivel I, Elliott JF, Boitard C, et al. Tolerance to proinsulin-2 is due to radioresistant thymic cells. J Immunol. 2006;177:53\u201360.","journal-title":"J Immunol"},{"key":"1347_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/db06-1248","volume":"56","author":"T Brusko","year":"2007","unstructured":"Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, et al. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes. 2007;56:604\u201312.","journal-title":"Diabetes"},{"key":"1347_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2567.2007.02546.x","volume":"121","author":"RJ Mellanby","year":"2007","unstructured":"Mellanby RJ, Thomas D, Phillips JM, Cooke A. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology. 2007;121:15\u201328.","journal-title":"Immunology"},{"key":"1347_CR45","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.4049\/jimmunol.1601118","volume":"197","author":"A Visperas","year":"2016","unstructured":"Visperas A, Vignali DA. Are regulatory T cells defective in type 1 diabetes and can we fix them? J Immunol. 2016;197:3762\u201370.","journal-title":"J Immunol"},{"key":"1347_CR46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B Salomon","year":"2000","unstructured":"Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431\u201340.","journal-title":"Immunity"},{"key":"1347_CR47","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","volume":"171","author":"Q Tang","year":"2003","unstructured":"Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol. 2003;171:3348\u201352.","journal-title":"J Immunol"},{"key":"1347_CR48","doi-asserted-by":"publisher","first-page":"14735","DOI":"10.1073\/pnas.0507014102","volume":"102","author":"Z Chen","year":"2005","unstructured":"Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci U S A. 2005;102:14735\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1347_CR49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.20041982","volume":"201","author":"R Setoguchi","year":"2005","unstructured":"Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723\u201335.","journal-title":"J Exp Med"},{"key":"1347_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","volume":"28","author":"Q Tang","year":"2008","unstructured":"Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 2008;28:687\u201397.","journal-title":"Immunity"},{"key":"1347_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coph.2018.07.007","volume":"43","author":"S Pellegrini","year":"2018","unstructured":"Pellegrini S, Piemonti L, Sordi V. Pluripotent stem cell replacement approaches to treat type 1 diabetes. Curr Opin Pharmacol. 2018;43:20\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"1347_CR52","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/pedi.12430","volume":"18","author":"KE McCabe","year":"2017","unstructured":"McCabe KE, Pollock AJ, Rehm JL, DeSantes KB. Curative potential of allogeneic hematopoietic stem cell transplant in type 1 diabetes. Pediatr Diabetes. 2017;18:832\u20134.","journal-title":"Pediatr Diabetes"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1347-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1347-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1347-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T21:44:17Z","timestamp":1695073457000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1347-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1347-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocols for animal studies were approved by the Institutional Animal Care and Use Committee of the University of Connecticut and were conducted in accordance with NIH guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}